#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis gene carrier Mantle cell lymphoma refractory Malignant central nervous system neoplasm Autoimmune demyelinating disease Malignant melanoma Palmar-plantar erythrodysaesthesia syndrome Erythema Hyperphagia Alpha-1 antitrypsin deficiency Drug eruption Erythema multiforme Ewing's sarcoma Heart disease congenital Heavy menstrual bleeding Hereditary hypophosphataemic rickets More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Trials in Disease Niemann-Pick disease – Life with Disease Nephroblastoma – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Life with Disease Undifferentiated sarcoma – Trials in Disease Pleomorphic leiomyosarcoma – Diagnostics Tuberous sclerosis complex – Life with Disease KBG syndrome Pemphigus – Treatment Krabbe’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Telitacicept BGB-16673 Caffeine Citrate Potassium Iodide M-(18F)-Fluorobenzylguanidine Osimertinib VIPOGLANSTAT Etamsylate Clemastine Cetrelimab Finasteride Vimseltinib Paltusotine Alprazolam Atropine Sulfate Monohydrate A3907 Neob Piracetam Mva-Hbvac GSK5458514 More therapies…

    Learn about Your Condition

    Embolic stroke Juvenile absence epilepsy Cortisol abnormal Oesophagectomy Endometriosis Peptostreptococcus infection Hepatic adenoma Body mass index increased Nocturia Leukoencephalopathy Wolfram syndrome Acute cardiac event Delirium Urinary incontinence Hyperkalaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Groupe Hospitalier Nord Essonne

Groupe Hospitalier Nord Essonne

4 Place Du General Leclerc, Orsay, 91400, France

Want to learn more about this study or check if you can participate? Contact us.

  • Evaluation of Cefazolin versus Placebo for Preventing Surgical Site Infection in Breast Cancer Lumpectomy Patients

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Cefazolin Sodium
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    France

  • Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Panitumumab
    • Sotorasib
    • Folinic Acid
    France Germany Italy Spain

  • Study on the Effectiveness of Calcium Folinate, Omega-3-Acid Ethyl Esters, and Cyanocobalamin for Patients at High Risk of Psychosis or Experiencing First Episode Psychosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Psychotic disorder
    Investigated Drugs:
    • Acetylcysteine
    • OMEGA-3-ACID ETHYL ESTERS 90
    • Cyanocobalamin
    France

  • Study on Antibiotic Treatments for Kidney Infection in Children: Comparing Cefixime, Ceftriaxone, and Amikacin for Ages 1 Month to 3 Years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Amikacin Sulfate
    • Bromhexine Hydrochloride
    • Cefixime Trihydrate
    France

  • Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Frexalimab
    Belgium Bulgaria Czechia France Germany Greece +7

  • Study on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Central nervous system lymphoma
    Investigated Drugs:
    • 18F-Fludarabine
    • Gadoteric Acid
    France

  • Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin
    • Amoxicillin Sodium
    • Aztreonam
    France
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!